[Pharmacological inhibition of ovulation].
Haller
J
J
D002715:Chlormadinone Acetate; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D005193:Family Planning Services; D008234:Lynestrenol; D008656:Mestranol; D009640:Norethindrone; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D008656:Mestranol; D008234:Lynestrenol; D009640:Norethindrone
Chlormadinone Acetate; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning; Lynestrenol; Mestranol; Norethindrone; Norethindrone Acetate; Oral Contraceptives; Oral Contraceptives, Combined; Oral Contraceptives, Phasic; Research Methodology; Reversibility